EZCORP shares fall despite record Q4 as costs overshadow beat
EZCORP's earnings call revealed a record Q4 beat, but shares fell 4.13% as investors focused on cost pressures flagged by management.
Markets
Delayed · 22:06 UK
Financial News
Martin Holloway spent the better part of two decades on bank trading floors in the City before he started filing copy. He read Economics at a redbrick university, joined a graduate scheme at one of the UK clearers in the late 1990s, and moved across to fixed income early in his career. The bulk of his time was on macro desks at European banks, running short-end and cross-asset positions through the 2008 crisis and the long grind of the post-crisis rates regime. He stepped off the desk toward the end of the last decade, did a stint consulting on the buy side, and started writing in 2020. He covers the bits of the City he actually knows: rates, FX, UK banks, gilt issuance, and the corporate news that moves them. He has a working theory about why nobody on the sell side saw the 2022 gilt crisis coming, and is happy to share it at moderate length. Martin lives in the South East with his family. He reads the FT in the morning out of habit rather than affection, and treats most market commentary as marketing collateral written by people who have never held risk overnight.
Covers
1–10 of 688
EZCORP's earnings call revealed a record Q4 beat, but shares fell 4.13% as investors focused on cost pressures flagged by management.
Edgewell fourth quarter results show $484.1m net sales, up 3.0%, as the Wet Shave maker guides FY27 EPS to $1.85-$2.15 and books fresh restructuring costs.
AIR Global net loss reached $74.2m over nine months, even as the group launched a dividend and $100m buyback funded by new debt.
Kraft Heinz investor day sets a 2029 double-digit shareholder return goal but warns 2027 organic sales will stay flat until growth resumes.
Ofcom fines Meta £596,700 over repeated inaccuracies in WhatsApp Business data, a penalty dwarfed by the group's quarterly profit.
China weight-loss pill approval for Eli Lilly's orforglipron puts it ahead of Novo Nordisk, Pfizer and Innovent in the country's obesity market.
Frontier First Class seats go on sale as the carrier's shares surge 64% in 20 days, even as GAAP losses widen for a fifth straight quarter.
Ouster's lidar toll deal with Indra expands an existing contract, but the real driver of the stock rally is a 50% revenue jump in Q3.
TON Strategy Q3 results show a $24m net loss and $13.1m revenue, even as the crypto-treasury firm's GRAM stake grew to 235.1 million tokens.
Ohio State University and Microsoft unveil a five-year strategic partnership on AI and cloud in healthcare, but no financial terms were disclosed.
Page 1 of 69